# Shrnutí článku

**Zdroj:** [sciencealert.com](https://www.sciencealert.com/new-weight-loss-drug-outperformed-existing-treatment-in-clinical-trial)

Under brand names like Ozempic and Wegovy, semaglutide-based medications have made a significant difference in treating type 2  diabetes and obesity.
After a successful phase 3 trial, a new kind of treatment based on the same mechanics could deliver even more impressive weight-loss results.
Like semaglutide, the new drug known as ecnoglutide is glucagon-like peptide-1 receptor agonist. In simple terms, they both mimic the body's natural GLP-1 hormone, helping boost insulin production, reduce appetite, and slow digestion to throttle blood sugar levels.
Related: Something Inside Your Gut Could B…